Abstract
Background
Methods
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineReferences
- Turmeric, the golden spice: from traditional medicine to modern medicine.in: Benzie IFF Wachtel-Galor S Herbal Medicine: Biomolecular and Clinical Aspects. 2nd. CRC Press/Taylor & Francis, Boca Raton, Fla2011: 263-288 (Available at:)
- Curcumin as a potential treatment for COVID-19.Front Pharmacol. 2021; 12675287
- Turmeric supplement induced hepatotoxicity: a rare complication of a poorly regulated substance.Clin Toxicol (Phila). 2020; 58: 216-217
- Turmeric induced liver injury: a report of two cases [e-pub ahead of print].Case Reports Hepatol. 2019; 2019 (Accessed October 22, 2022)6741213https://doi.org/10.1155/2019/6741213
- Turmeric-associated liver injury.Am J Ther. 2020; 27: e642-e645
- Acute liver injury following turmeric use in Tuscany: an analysis of the Italian Phytovigilance database and systematic review of case reports.Br J Clin Pharmacol. 2021; 87: 741-753
- Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease.J Clin Psychopharmacol. 2008; 28: 110-113
- Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study.Alzheimer's Res Ther. 2012; 4: 43-50
- Systematic and comprehensive investigation of the toxicity of curcuminoid essential oil complex: a bioavailable turmeric formulation.Mol Med Rep. 2016; 13: 592-604
- The efficacy of Curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial.J Med Assoc Thai. 2012; 95: S51-S58
- Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.Radiat Res. 2013; 180: 34-35
- The essential medicinal chemistry of curcumin.J Med Chem. 2017; 60: 1620-1637
- Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice.Cancer Res Treat. 2014; 46: 2-18
- United States Drug Induced Liver Injury Network. Features and outcomes of 889 patients with drug-induced liver injury: the DILIN Prospective Study.Gastroenterology. 2015; 148: 1340-1352
- Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct.Drug Saf. 2009; 32: 55-68
- Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network.Hepatology. 2014; 60: 1399-1408
- Liver injury from herbal and dietary supplements.Hepatology. 2017; 65: 363-373
- Drug-Induced Liver Injury Network. Garcinia cambogia, either alone or in combination with green tea, causes moderate to severe liver injury.Clin Gastroenterol Hepatol. 2022; 20: e1416-e1425
- Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.Hepatology. 2014; 59: 661-670
- HLA-B*35:01 and green tea-induced liver injury.Hepatology. 2021; 73: 2484-2493
- HLA-B*35:01 allele is a potential biomarker for predicting Polygonum multiflorum-induced liver injury.Hepatology. 2019; 70: 346-357
Nutraceuticals World. Herbal dietary supplement sales surpass $11 billion, fueled by immune health, stress support & combination products. Available at: nutraceuticalsworld.com/contents/view_breaking-news/2021-09-15/herbalgram-publishes-2020-herb-market-report/.
Bedosky L. 12 Scientific health benefits of turmeric and curcumin. Available at: everydayhealth.com/diet-nutrition/diet/scientific-health-benefits-turmeric-curcumin/.
- Turmeric and its major compound curcumin on health: bioactive effects and safety profiles for food, pharmaceutical, biotechnological and medicinal applications.Front Pharmacol. 2020; 15: 01021
Article Info
Publication History
Publication stage
In Press Journal Pre-ProofFootnotes
Funding: Funded as a Cooperative Agreement by National Institute of Diabetes and Digestive and Kidney Diseases with support from the Intramural Division of the National Cancer Institute, National Institutes of Health, Bethesda, Md (to the Drug‐induced Liver Injury Network [https://dilin.dcri.duke.edu/]): U01‐DK065176 and U24‐DK065176 (Duke University), U01‐DK065211 (Indiana University), U01‐DK065201 (University of North Carolina), U01‐ DK065184 (University of Michigan), U01‐DK065193 (University of Connecticut), U01‐DK065238 (University of California San Francisco/California Pacific Medical Center), U01‐DK083023 (University of Texas‐Southwestern), U01‐DK083020 (University of Southern California), U01‐DK082992 (Mayo Clinic), U01‐DK083027 (Thomas Jefferson/Albert Einstein Medical Center, University of Pennsylvania), and U01‐DK100928 (Icahn School of Medicine at Mount Sinai) ClinicalTrials.gov Number: NCT00345930.
Conflicts of Interest: None.
Authorship: DHD's contributions included study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content and statistical analysis. VN: Study concept and design; acquisition of data; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; statistical analysis; obtained funding; study supervision. JA: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. BA: Analysis and interpretation of data; critical revision of the manuscript for important intellectual content. HB: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content, statistical analysis. ASB: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. HLB: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. RJF: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. MSG: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. JHH: Study concept and design; analysis and interpretation of data; drafting of the manuscript; critical revision of the manuscript for important intellectual content; statistical analysis; study supervision. IAK: Analysis and interpretation of data; critical revision of the manuscript for important intellectual content. DEK: Analysis and interpretation of data; critical revision of the manuscript for important intellectual content. EP: Analysis and interpretation of data; critical revision of the manuscript for important intellectual content. AS: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content. RV: Study concept and design; acquisition of data; analysis and interpretation of data critical revision of the manuscript for important intellectual content.
